AA
ALPS Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
+67,761
| New | +$1.17M | 0.01% | 469 |
|
|
2021
Q4 | – | Sell |
-106,632
| Closed | -$3.52M | – | 893 |
|
|
2021
Q3 | $3.52M | Buy |
106,632
+1,008
| +1% | +$33.2K | 0.03% | 198 |
|
|
2021
Q2 | $6.68M | Sell |
105,624
-31,395
| -23% | -$1.98M | 0.06% | 161 |
|
|
2021
Q1 | $5.88M | Buy |
137,019
+365
| +0.3% | +$15.7K | 0.06% | 167 |
|
|
2020
Q4 | $7.82M | Buy |
136,654
+40,239
| +42% | +$2.3M | 0.09% | 150 |
|
|
2020
Q3 | $2.91M | Sell |
96,415
-6,598
| -6% | -$199K | 0.04% | 193 |
|
|
2020
Q2 | $3.36M | Sell |
103,013
-30,505
| -23% | -$996K | 0.05% | 183 |
|
|
2020
Q1 | $3.58M | Buy |
133,518
+4,822
| +4% | +$129K | 0.06% | 169 |
|
|
2019
Q4 | $3.94M | Buy |
128,696
+1,640
| +1% | +$50.2K | 0.03% | 174 |
|
|
2019
Q3 | $3.06M | Sell |
127,056
-5,295
| -4% | -$128K | 0.02% | 182 |
|
|
2019
Q2 | $3.35M | Sell |
132,351
-3,497
| -3% | -$88.6K | 0.02% | 179 |
|
|
2019
Q1 | $2.65M | Buy |
135,848
+5,875
| +5% | +$115K | 0.02% | 200 |
|
|
2018
Q4 | $1.71M | Buy |
129,973
+30,560
| +31% | +$403K | 0.01% | 233 |
|
|
2018
Q3 | $1.77M | Buy |
99,413
+18,231
| +22% | +$324K | 0.01% | 266 |
|
|
2018
Q2 | $1.79M | Buy |
+81,182
| New | +$1.79M | 0.01% | 241 |
|